Liver fibrosis -- from bench to bedside - PubMed (original) (raw)

Review

Liver fibrosis -- from bench to bedside

Scott L Friedman. J Hepatol. 2003.

No abstract available

PubMed Disclaimer

Similar articles

• Fibrosis and cirrhosis reversibility: clinical features and implications.
  Pinzani M, Vizzutti F. Pinzani M, et al. Clin Liver Dis. 2008 Nov;12(4):901-13, x. doi: 10.1016/j.cld.2008.07.006. Clin Liver Dis. 2008. PMID: 18984473 Review.
• Fibrosis in chronic liver diseases: diagnosis and management.
  Pinzani M, Rombouts K, Colagrande S. Pinzani M, et al. J Hepatol. 2005;42 Suppl(1):S22-36. doi: 10.1016/j.jhep.2004.12.008. Epub 2004 Dec 24. J Hepatol. 2005. PMID: 15777570 Review. No abstract available.
• Liver fibrosis.
  Burt AD. Burt AD. BMJ. 1992 Sep 5;305(6853):537-8. doi: 10.1136/bmj.305.6853.537. BMJ. 1992. PMID: 1393030 Free PMC article. No abstract available.
• Update on the pathophysiology of liver fibrosis.
  Pinzani M, Macias-Barragan J. Pinzani M, et al. Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):459-72. doi: 10.1586/egh.10.47. Expert Rev Gastroenterol Hepatol. 2010. PMID: 20678019 Review.
• Cystic Fibrosis-related cirrhosis.
  Leung DH, Narkewicz MR. Leung DH, et al. J Cyst Fibros. 2017 Nov;16 Suppl 2:S50-S61. doi: 10.1016/j.jcf.2017.07.002. J Cyst Fibros. 2017. PMID: 28986027 Review.

Cited by

• The role of forkhead box M1-methionine adenosyltransferase 2 A/2B axis in liver inflammation and fibrosis.
  Yang B, Lu L, Xiong T, Fan W, Wang J, Barbier-Torres L, Chhimwal J, Sinha S, Tsuchiya T, Mavila N, Tomasi ML, Cao D, Zhang J, Peng H, Mato JM, Liu T, Yang X, Kalinichenko VV, Ramani K, Han J, Seki E, Yang H, Lu SC. Yang B, et al. Nat Commun. 2024 Sep 27;15(1):8388. doi: 10.1038/s41467-024-52527-8. Nat Commun. 2024. PMID: 39333125 Free PMC article.
• STA-9090 in combination with a statin exerts enhanced protective effects in rats fed a high-fat diet and exposed to diethylnitrosamine and thioacetamide.
  Abdelhamid AM, Saber S, Hamad RS, Abdel-Reheim MA, Ellethy AT, Amer MM, Abdel-Hamed MR, Mohamed EA, Ahmed SS, Elsisi HA, Khodeir MM, Alkhamiss AS, A AA, Abu Elgasim MAE, Almansour ZH, Elesawy BH, Elmorsy EA. Abdelhamid AM, et al. Front Pharmacol. 2024 Sep 4;15:1454829. doi: 10.3389/fphar.2024.1454829. eCollection 2024. Front Pharmacol. 2024. PMID: 39309001 Free PMC article.
• The role of 2'-5'-oligoadenylate synthase-like protein (OASL1) in biliary and hepatotoxin-induced liver injury in mice.
  Leya M, Yang D, Bao THTN, Jeong H, Oh SI, Kim JH, Kim JW, Kim B. Leya M, et al. Sci Rep. 2024 Sep 19;14(1):21873. doi: 10.1038/s41598-024-72465-1. Sci Rep. 2024. PMID: 39300174 Free PMC article.
• Induction of hepatic fibrosis in mice with schistosomiasis by extracellular microRNA-30 derived from Schistosoma japonicum eggs.
  Chen Y, Hu Y, Zhou H, Jiang N, Wang Y, Zhang J, Shen Y, Yu G, Cao J. Chen Y, et al. Front Immunol. 2024 Jul 30;15:1425384. doi: 10.3389/fimmu.2024.1425384. eCollection 2024. Front Immunol. 2024. PMID: 39139565 Free PMC article.
• Mesenchymal stem cells-derived exosomes alleviate liver fibrosis by targeting Hedgehog/SMO signaling.
  Zong R, Zheng Y, Yan Y, Sun W, Kong L, Huang Y, Liu Y, Jiang C, Ping J, Li C. Zong R, et al. Hepatol Int. 2024 Aug 13. doi: 10.1007/s12072-024-10717-y. Online ahead of print. Hepatol Int. 2024. PMID: 39138757

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information